CapForce IBD Breakout Opportunities ETF (BOUT) price, chart and fund profile

Price chart

Fund profile

BOUT seeks to provide exposure to the investment results of the IBD Breakout Stocks Index. The Index leverages decades of Investor's Business Daily research and seeks to identify stock breakout opportunities, or stocks poised to experience a period of sustained price growth beyond the security's recent "resistance level", with consideration for various market conditions.

Issuer

M2 Financial LLC

Industry

—

Inception

Sep 13, 2018

Assets under management

$15.5M

Expense ratio

0.80%

Net asset value

$44.16

NAV as of

Aug 28, 2026

Distributions

Annually

Leverage

1×

Fund page

www.capforceetf.com↗

• What is CapForce IBD Breakout Opportunities ETF (BOUT)?

  BOUT seeks to provide exposure to the investment results of the IBD Breakout Stocks Index. The Index leverages decades of Investor's Business Daily research and seeks to identify stock breakout opportunities, or stocks poised to experience a period of sustained price growth beyond the security's recent "resistance leve…

• What is BOUT's expense ratio?

  CapForce IBD Breakout Opportunities ETF charges an annual expense ratio of 0.80%. The fund is issued by M2 Financial LLC.

• How large is BOUT?

  CapForce IBD Breakout Opportunities ETF manages $15.5M in assets and has traded since Sep 13, 2018.

• How do I buy shares of CapForce IBD Breakout Opportunities ETF (BOUT)?

  BOUT trades commission-free with a Light Horse Securities brokerage account — from the mobile app, the web dashboard at portal.lighthorse.io, the trading API, or an AI agent connected over MCP. The trade panel on this page places the order once you are signed in.